Legal Cannabis Global Market Insights 2025, Featuring Profiles of Key Players Aurora Cannabis, Canopy Growth, Tilray, Green Thumb, GW Pharmaceuticals, Sundial Growers, The Cronos Group & VIVO Cannabis
14 janv. 2025 07h03 HE
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Legal Cannabis Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type"...
Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis
06 janv. 2025 07h00 HE
|
Tilray Brands, Inc.
This Luxembourg tender win marks Tilray Medical's further expansion through Europe.
Conventional and Alternative Pain Treatment Market Research 2024-2029: Expanding Usage of Wearable Devices, and Increasing Integration of Artificial Intelligence in Medical Devices Bodes Well
31 déc. 2024 05h26 HE
|
Research and Markets
Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Conventional and Alternative Pain Treatment Market" report has been added to ResearchAndMarkets.com's offering.The Conventional and Alternative Pain...
Europe Medical Cannabis Snapshot Report 2024: Germnay, UK, Poland, Czech Republic, Switzerland Market Sizes, Top Brands, Product Forms, Consumption Patterns, Product Origin, and Regulatory Landscapes
03 déc. 2024 04h27 HE
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Cannabis Snapshot Bundle" report has been added to ResearchAndMarkets.com's offering. The Europe Medical Cannabis Snapshot Bundle...
Global and US CBD Regulatory Database 2024: Essential Information About How CBD is Regulated in Key Markets to Ensure your Business Complies with All Legal Requirements
27 nov. 2024 04h13 HE
|
Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Global CBD Regulatory Database" database has been added to ResearchAndMarkets.com's offering. This database bundle provide essential information...
Global and United States Medical and Recreational Cannabis Database 2024: Legal Status, Production and Licensing, Consumption and Prescription, Legal Proposals and Political Initiatives
27 nov. 2024 04h12 HE
|
Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Medical and Recreational Cannabis Database" database has been added to ResearchAndMarkets.com's offering. This dataset provides essential...
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
14 nov. 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray Medical announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility.
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
07 nov. 2024 07h00 HE
|
Tilray Brands, Inc.
This trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from negative chemotherapy-induced side effects.
International Directory of Medical Cannabis Companies 2024
04 oct. 2024 04h54 HE
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "International Directory of Medical Cannabis Companies 2024" directory has been added to ResearchAndMarkets.com's offering.The International Directory...
Tilray Medical Launches Redecan Cannabis Brand in Australia
18 sept. 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray's EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription.